Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Status:
Withdrawn
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. O(6)-benzylguanine may increase the effectiveness of carmustine by
making tumor cells more sensitive to the drug.
PURPOSE: Phase II trial to study the effectiveness of combining carmustine with
O(6)-benzylguanine in treating patients who have newly diagnosed supratentorial glioblastoma
multiforme.